Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan-Reference-Cited by-同舟云学术

Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan

Published:2019-03-28 Issue:5 Volume:110 Page:1686-1694
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Munakata Wataru¹^ORCID,Ando Kiyoshi²,Hatake Kiyohiko³,Fukuhara Noriko⁴,Kinoshita Tomohiro⁵,Fukuhara Suguru¹,Shirasugi Yukari²,Yokoyama Masahiro³,Ichikawa Satoshi⁴,Ohmachi Ken²^ORCID,Gion Naokazu⁶,Aoi Arata⁷,Tobinai Kensei¹

Affiliation:

1. Department of HematologyNational Cancer Center Hospital Tokyo Japan

2. Department of Hematology and OncologyTokai University Isehara Japan

3. Department of Hematology and OncologyCancer Institute HospitalJapanese Foundation for Cancer Research Tokyo Japan

4. Department of Hematology and RheumatologyTohoku University Graduate School of Medicine Sendai Japan

5. Department of Hematology and Cell TherapyAichi Cancer Center Nagoya Japan

6. Department of Statistical AnalysisOno Pharmaceutical Co., Ltd.Osaka Japan

7. Department of Oncology Clinical Development PlanningOno Pharmaceutical Co., Ltd. Osaka Japan

Funder

Ono Pharmaceutical Co., Ltd

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13983

Reference17 articles.

1. Regulation of B-cell fate by antigen-receptor signals

2. Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

3. Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

4. Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

5. Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proportion of Newly Detected Hypothyroidism among the Diabetic and Nondiabetic Pregnant Ladies and Correlation of Different Parameters with Thyroid Stimulatory Hormone in Pregnancy Attending a Tertiary Care Hospital;Bangladesh Journal of Endocrinology and Metabolism;2024-05-10

2. Assessing the Diagnostic Impact of p53, p16, Retinoblastoma and bcl-2 Proteins in Human Papillomavirus-associated Squamous Cell Carcinoma of the Cervix;Journal of Preventive, Diagnostic and Treatment Strategies in Medicine;2024-04

3. Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma;Neuro-Oncology Advances;2024-01-01

4. A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications;Molecules;2023-12-11

5. SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-10